ClinicalTrials.gg
CompletedNCT03413371PBBVRSUpdated May 28, 2026

Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)

An interventional study of paracetamol and 0,5 % bupivacaine with of 2% lidocaine in Vitreoretinal Surgeries, Postoperative Nausea and Vomiting and Postoperative Pain, sponsored by Medical University of Silesia. Completed at 1 site in Poland. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-05-28.

Sponsored by Medical University of Silesia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
184
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The aim of this randomized trial is to assess the efficacy of preventive analgesia using different peribulbar blocks (PBB) under SPI-guided anaesthesia for vitreoretinal surgery (VRS), presence of PONV (postoperative nausea and vomiting) and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively.

Patients will receive general anaesthesia combined with either preventive PBB using either lidocaine with bupivacaine or bupivacaine or ropivacaine

Read the detailed description

Monitoring depth of anaesthesia using spectral entropy (SE) and quality of neuromuscular block are routine in modern anaesthesia, whereas monitoring of analgesia still requires further studies. Recently, the Surgical Pleth Index (SPI) was added as a surrogate variable showing the nociception-antinociception balance into abovementioned parameters constituting a novel approach in monitoring patients intraoperatively, known as adequacy of anaesthesia (AoA) or tailor-made anaesthesia.

Different options of local anesthetic mixtures used for peribulbar block result in different analgetic potency. PBB is supposed to reduce requirement for intraoperative narcotic analgesics when used together with general anaesthesia and therefore may reduce the rate of PONV, OCR and perception of postoperative pain.

The aim of the study is to investigate the influence of different PBBs on abovementioned outcomes.

02

Conditions studied

  • Vitreoretinal Surgeries
  • Postoperative Nausea and Vomiting
  • Postoperative Pain
  • Oculocardiac Reflex

Keywords

  • Surgical Pleth Index (SPI)
  • General Anaesthesia (GA),
  • Numerical Rating Scale (NRS)
  • Adequacy of Anaesthesia (AoA)
  • Peribulbar Block (PBB)
  • bupivacaine
  • ropivacaine
  • lidocaine
03

In context

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

This study's enrollment of 184 is above the median of 112 across 529 interventional studies indexed under Postoperative Nausea and Vomiting.

Browse Postoperative Nausea and Vomiting studies →

Lead sponsor

Medical University of Silesia is the lead sponsor of 115 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • written consent to participate in the study written consent to undergo general anaesthesia alone or combined with different techniques of pre-emptive analgesia and vitreoretinal surgery

Exclusion criteria

Exclusion Criteria:

  • history of allergy to local anaesthetics or paracetamol necessity of administration of vasoactive drugs influencing SPI monitoring pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
184 participants (actual)

Study arms

  • Experimental
    0,5 % bupivacaine with of 2% lidocaine

    in group BL patients in group BF will receive regional peribulbar block using a solution of 0,5% bupivacaine (2,5 ml) with 2% lidocaine (2,5 ml)

    Drug: paracetamol · Drug: 1 % Ropivacaine · Drug: 0,5 % bupivacaine

  • Experimental
    0,5 % bupivacaine

    in group B patients in group BF will receive regional peribulbar block using a solution of 0,5% bupivacaine (5 ml)

    Drug: paracetamol · Drug: 0,5 % bupivacaine with of 2% lidocaine · Drug: 1 % Ropivacaine

  • Experimental
    1 % ropivacaine

    in group RL patients in group BF will receive regional peribulbar block using a solution of 1% ropivacaine (5 ml)

    Drug: paracetamol · Drug: 0,5 % bupivacaine with of 2% lidocaine · Drug: 0,5 % bupivacaine

  • Experimental
    paracetamol

    in P group patients will receive preemptive analgesia using 1 gram of paracetamol before induction of general anaesthesia

    Drug: 0,5 % bupivacaine with of 2% lidocaine · Drug: 1 % Ropivacaine · Drug: 0,5 % bupivacaine

Interventions

  • in group P patients will receive pre-emptive analgesia using intravenous infusion of acetaminophen in a single dose of 10-15 mg per kg of body weight

  • Drug0,5 % bupivacaine with of 2% lidocaine

    Drug page: Bupivacaine

    in group BL patients will receive regional peribulbar block using a solution of 0,5% bupivacaine (2,5 ml) with 2% lidocaine (2,5 ml)

    Also known as: Bupivacaine, Lidocaine

  • in group R patients will receive regional peribulbar block using a solution of 0,75 % ropivacaine (5 ml)

    Also known as: ropivacaine

  • in group B patients will receive regional peribulbar block using a solution of 0,5% bupivacaine (5 ml)

    Also known as: bupivacaine

06

What researchers measure

Primary outcomes

  1. pain perception intraoperatively

    The investigators will compare the efficacy of analgesia intraoperatively according to technique of analgesia used preoperatively: either peribulbar block or intravenous infusion. The investigators will administer a rescue dose of fentanyl intravenously in a dose of 1 mcg per kg of body weight in the case when SPI (surgical pleh index value) value increases over 15 points in SPI scale every 5 minutes until SPI value decreases back to baseline value. Additionally, the investigators will analyse rescue fentanyl consumption in abovementioned groups

    Time frame: intraoperative assessment

Secondary outcomes

  1. oculocardiac reflex rate

    the investigators will compare the rate of presence of OCR intraoperatively in studied groups observing the presence of heart rate (HR) rapid decrease by 30%.

    Time frame: intraoperative assessment

  2. pain perception postoperatively

    The investigators will compare the efficacy of analgesia postoperatively according to technique of analgesia used preoperatively: sort of anaesthetic mixture used for peribulbar block. The investigators will use the numeric rating scale (NRS) and compare it with surgical pleth index value (SPI) for certain pain perception: mild, moderate, acute.

    Time frame: up to one hour after discharge to postoperative unit performed every 10 minutes.

  3. PONV (postoperative nausea and vomiting)

    The investigators will compare the presence of every incident of PONV after emergence from GA in studied groups and use predictive Apfel Score

    Time frame: postoperative assessment up to 24 hours

07

Study locations

1 site
  • Medical University of Silesia
    Sosnowiec, Silesian Voivodeship 41-200, Poland
08

References and documents

Publications

  • Gruenewald M, Herz J, Schoenherr T, Thee C, Steinfath M, Bein B. Measurement of the nociceptive balance by Analgesia Nociception Index and Surgical Pleth Index during sevoflurane-remifentanil anesthesia. Minerva Anestesiol. 2015 May;81(5):480-9. Epub 2014 Jul 17. PubMed 25032676 ↗
  • Gruenewald M, Ilies C, Herz J, Schoenherr T, Fudickar A, Hocker J, Bein B. Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia. Br J Anaesth. 2013 Jun;110(6):1024-30. doi: 10.1093/bja/aet019. Epub 2013 Mar 6. PubMed 23471754 ↗
  • Gruenewald M, Ilies C. Monitoring the nociception-anti-nociception balance. Best Pract Res Clin Anaesthesiol. 2013 Jun;27(2):235-47. doi: 10.1016/j.bpa.2013.06.007. PubMed 24012235 ↗
  • Gruenewald M, Willms S, Broch O, Kott M, Steinfath M, Bein B. Sufentanil administration guided by surgical pleth index vs standard practice during sevoflurane anaesthesia: a randomized controlled pilot study. Br J Anaesth. 2014 May;112(5):898-905. doi: 10.1093/bja/aet485. Epub 2014 Feb 16. PubMed 24535604 ↗
  • Jaichandran VV, Raman R, Gella L, Sharma T. Local anesthetic agents for vitreoretinal surgery: no advantage to mixing solutions. Ophthalmology. 2015 May;122(5):1030-3. doi: 10.1016/j.ophtha.2014.11.026. Epub 2015 Jan 10. PubMed 25582785 ↗
  • Ghali AM. The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery. Saudi J Anaesth. 2012 Jan;6(1):22-6. doi: 10.4103/1658-354X.93050. PubMed 22412772 ↗
  • Seidenari P, Santin G, Milani P, David A. Peribulbar and retrobulbar combined anesthesia for vitreoretinal surgery using ropivacaine. Eur J Ophthalmol. 2006 Mar-Apr;16(2):295-9. doi: 10.1177/112067210601600216. PubMed 16703549 ↗
  • Subramaniam R, Subbarayudu S, Rewari V, Singh RP, Madan R. Usefulness of pre-emptive peribulbar block in pediatric vitreoretinal surgery: a prospective study. Reg Anesth Pain Med. 2003 Jan-Feb;28(1):43-7. doi: 10.1053/rapm.2003.50032. PubMed 12567343 ↗
  • Fekrat S, Elsing SH, Raja SC, Campochiaro PA, de Juan E Jr, Haller JA. Eye pain after vitreoretinal surgery: a prospective study of 185 patients. Retina. 2001;21(6):627-32. doi: 10.1097/00006982-200112000-00010. PubMed 11756886 ↗
  • Calenda E, Olle P, Muraine M, Brasseur G. Peribulbar anesthesia and sub-Tenon injection for vitreoretinal surgery: 300 cases. Acta Ophthalmol Scand. 2000 Apr;78(2):196-9. doi: 10.1034/j.1600-0420.2000.078002196.x. PubMed 10794256 ↗
  • Sajedi P, Nejad MS, Montazeri K, Baloochestani E. Comparing the preventive effect of 2 percent topical lidocaine and intravenous atropine on oculocardiac reflex in ophthalmological surgeries under general anesthesia. Int J Prev Med. 2013 Nov;4(11):1258-65. PubMed 24404359 ↗
  • Calenda E, Quintyn JC, Brasseur G. Peribulbar anaesthesia using a combination of lidocaine, bupivocaine and clonidine in vitreoretinal surgery. Indian J Ophthalmol. 2002 Sep;50(3):205-8. PubMed 12355695 ↗
  • Mandelcorn M, Taback N, Mandelcorn E, Ananthanarayan C. Risk factors for pain and nausea following retinal and vitreous surgery under conscious sedation. Can J Ophthalmol. 1999 Aug;34(5):281-5. PubMed 10486687 ↗

Individual participant data

Plan to share: Yes

Supporting information: Informed consent form

Time frame: article in Anesthesiology and Intensive Therapy in 2021, case reports

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2018 to primary completion in Dec 2022, 55 months.

Of 181 non-industry interventional studies with no phase under Postoperative Nausea and Vomiting, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 55 months is above that.

Counting every sponsor, half of 181 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 27, 2017
First posted
Jan 29, 2018
StartActual
Apr 26, 2018
Primary completionActual
Dec 20, 2022
CompletionActual
Dec 20, 2022
Last update
May 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03413371
Collaborators
Silesian University of Medicine
Responsible party
Sponsor
First posted
Jan 29, 2018
Start date
Apr 26, 2018
Primary completion
Dec 20, 2022
Completion
Dec 20, 2022
Last update
May 28, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Acetaminophen · Bupivacaine · Ropivacaine

Start the discussion